Milestone Pharmaceuticals Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Milestone Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Quebec, Canada
- Headquarters city
- Montreal
- Headquarters country
- Canada
- Fiscal year end
- December
- Ticker symbol
- MIST
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001408443
Board of directors
-
Andrew Saik · DirectorSince 2024
-
Debra K. Liebert · DirectorSince 2023
-
Joseph C. Papa · DirectorSince 2024
-
Joseph Oliveto · Director · President and CEOSince 2023
-
Lisa M. Giles · DirectorSince 2023
-
Michael John Tomsicek · DirectorSince 2023
-
Richard C. Pasternak · DirectorSince 2023
-
Robert James Wills · DirectorSince 2023
-
Seth H. Z. Fischer · DirectorSince 2023
-
Stuart Duty · DirectorSince 2024
Chief executives
Joseph Oliveto
· President and CEO
Dates unknown
Director election results
Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
85.7%
-
85.9%
-
87.6%
-
88.1%
-
88.4%
-
88.5%
-
88.5%
-
88.5%
Board connections
5 of this board's directors also sit on 8 other boards.
- via Stuart Duty
- via Michael John Tomsicek
- via Robert James Wills
- via Joseph C. Papa
- via Joseph C. Papa
- via Stuart Duty
- via Stuart Duty
- via Lisa M. Giles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $1,176,157
- 13 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 16, 2026 | Joseph Oliveto Director, Officer (President and CEO) | Open-market sale | −36,500 | $2.26 | $82,490 |
| Jan 26, 2026 | Bharucha David Officer (Chief Medical Officer) | Option exercise | +20,100 | — | — |
| Jan 26, 2026 | Nelson Jeffrey Edward Officer (Chief Operating Officer) | Option exercise | +20,100 | — | — |
| Jan 26, 2026 | Muller Lorenz Officer (Chief Commercial Officer) | Option exercise | +20,100 | — | — |
| Jan 26, 2026 | Hasija Amit Officer (CFO & EVP of Corp. Development) | Option exercise | +20,100 | — | — |
| Jan 26, 2026 | Joseph Oliveto Director, Officer (President and CEO) | Option exercise | +66,600 | — | — |
| Jan 26, 2026 | Bharucha David Officer (Chief Medical Officer) | Open-market sale | −12,245 | $1.93 | $23,633 |
| Jan 26, 2026 | Nelson Jeffrey Edward Officer (Chief Operating Officer) | Open-market sale | −12,245 | $1.93 | $23,633 |
| Jan 26, 2026 | Muller Lorenz Officer (Chief Commercial Officer) | Open-market sale | −11,180 | $1.93 | $21,577 |
| Jan 26, 2026 | Hasija Amit Officer (CFO & EVP of Corp. Development) | Open-market sale | −12,245 | $1.93 | $23,633 |
| Jan 26, 2026 | Joseph Oliveto Director, Officer (President and CEO) | Open-market sale | −34,523 | $1.93 | $66,629 |
| Jan 8, 2026 | Joseph Oliveto Director, Officer (President and CEO) | Open-market sale | −43,000 | $2.25 | $96,750 |
| Jan 7, 2026 | Joseph Oliveto Director, Officer (President and CEO) | Open-market sale | −500 | $2.25 | $1,125 |
| Dec 15, 2025 | Bharucha David Officer (Chief Medical Officer) | Open-market sale | −58,007 | $2.32 | $134,576 |
| Dec 15, 2025 | Nelson Jeffrey Edward Officer (Chief Operating Officer) | Open-market sale | −58,007 | $2.32 | $134,576 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.